Skip to main content
claim Posted by admin September 03, 2026 at 09:01 AM
Moderna and Merck should license their personalized vaccine technology to generic manufacturers to ensure global access.
Vote options for this statement: agree, disagree, or unsure
Vote to see results

Responses & Discussion

Log in to add your response to this statement

Log In

No responses yet. Be the first to share your perspective!